 |
|
|
|
|
|
|
Bioforum International |
|
|
|
Upcoming
2011
TBA
Day Course
|
Technical Files - Assembling, Preparing and Writing for the MDD
Lecturer: Dr. Christian Jarling
|
| |
|
 |
TBA
3 - Day Course
|
The Analysis and Characterization of Protein Therapeutic Drugs
Lecturer: Mr. David Carr
|
| |
|
 |
TBA
2 - Day Course
|
Preparative High Performance Liquid Chromatography
Lecturer: Dr. Henri Colin
|
| |
This course is intended for production managers, chemical engineers and chemists in the pharmaceutical industry who want to understand the principles of PHPLC and some of its key features for successful applications at pilot and production levels.
|
 |
TBA
2 - Day Course
|
Biocompatibility Evaluation of Medical Device & Biomaterials
Lecturer: Dr. Shayne Gad
|
| |
The goal of this course is to enable you to develop new medical devices faster, more efficiently and with less expense by giving you a practical working knowledge of biocompatibility and device development. |
 |
TBA
Day Course
|
Efficient Management in Quality Operation
Lecturer: Mr. Rafi Maslaton
|
| |
|
 |
TBA
2 - Day Course
|
Quantitative Analysis by LC–MS
Lecturer: Dr. Wilfried Niessen
|
| |
One of the most important applications of LC–MS is its use in routine quantitative analysis, in preclinical and clinical studies to sustain drug development, and in food safety and environmental analysis. This two-day course pays specific attention to aspects related to quantitative analysis by LC–MS for pharmaceutical applications as well as quantitative (multi)residue analysis by LC–MS for environmental and food-safety applications.
|
 |
TBA
2 - Day Course
|
Sterilization by Ethylene Oxide
Lecturer: Mr. Daniel Floyd
|
| |
|
 |
TBA
Day Course
|
Troubleshooting in Sterilization & Microbiological Testing of MD
Lecturers: Mr. Daniel Floyd, Mr. Martell Winters
|
| |
|
 |
TBA
3 - Day Course
|
Non-Clinical Drug Safety Evaluation and Drug Development
Lecturer: Dr. Shayne Gad
|
| |
This course provides a comprehensive explanation of the non-clinical development of drugs, biologics and combination products, emphasizing the principles of pharmaceutical toxicology and the assessment of product safety. In addition to the different types of toxicity studies in modern pharmaceutical development, it also describes the relationship between pharmacology, clinical trial design, regulatory strategy and project management.
|
 |
TBA
2 - Day Course
|
Marketing Authorization of Biologicals in the EU
Lecturer: Dr. Barbara Jentges
|
| |
This course focuses on the legislative environment regulating biologicals within the European Union and gives an understanding of the regulatory steps that need to be taken to successfully place a biological on the European market. |
 |
TBA
Day Course
|
Introduction to Bioassay for Non-Biologists
Lecturer: Dr. Ana Menendez, USA
|
| |
|
 |
22/05/2011
3 - Day Course
|
Role, Responsibilities and Activities of the Qualified Person in the European Union
Lecturers: Dr. Christopher Burgess, Mr. Richard Bonner
|
| |
|
 |
25/05/2011
Day Course
|
The Role of the Qualified Person (QP) of Pharmaceutical and Veterinary Manufacturers and Importers in Israel
Lecturers: Dr. Christopher Burgess, Mr. Richard Bonner
|
| |
|
 |
26/05/2011
Day Course
|
Writing and Understanding Technical Agreements
Lecturers: Dr Christopher Burgess, Mr. Richard Bonner
|
| |
|
 |
2010
12/09/2010
2 - Day Course
|
Retrieving Compound Identity Using LC–MS–MS
Lecturer: Dr. Wilfried Niessen
|
| |
This two-day course provides knowledge for structure elucidation of small molecules (drugs, pesticides, natural products, etc.) by combined liquid chromatography–tandem mass spectrometry (LC–MS–MS). We study the fragmentation of positively and negatively charged even-electron ions in MS–MS, and discuss identification strategies, both from data-acquisition and from data-processing point of view. Next to lectures and time for questions and discussion, the Course provides exercises in order to practice spectral interpretation. |
 |
08/11/2010
2 - Day Course
|
Building eCTD-compliant Documents and Preparing an eCTD Submission
Lecturer: Dr. Barbara Jentges
|
| |
This course will give an understanding for ‘eCTD’ and the differing regional requirements. Aspects for the preparation of ‘eCTD-compliant’ documents will be discussed in detail during practical examples.
|
 |
08/11/2010
Day Course
|
A GMP Inspector’s Perspective on Compliance
Lecturer: Mr. Michael Anisfeld, USA
|
| |
Effective Quality Risk Management and Corrective + Preventive Action (CAPA) Systems.
Minimize Failure, Maximize Profits and Effectively Meet the Latest GMP Compliance Requirements from Inspection Agencies World-wide. Total Compliance to EU GMPs Annex 20 – “Quality Risk Management”
|
 |
16/11/2010
3 - Day Course
|
Stabilization of Proteins and Peptides along the Formulation Process
Lecturer: Dr. Mark Cornell Manning
|
| |
|
 |
22/11/2010
2 - Day Course
|
MedDRA® : A Comprehensive Training Course
Lecturer: Dr Elliot Brown
|
| |
|
 |
24/11/2010
Day Course
|
Tablet Pro
Lecturer: Mr. Michael Tousey, USA
|
| |
Tablet Pro (Professional) is a one day comprehensive course covering tablet press operations. The participant will gain a complete understanding of the importance of tablet press set-up, machine function, operation, and cleaning. |
 |
30/11/2010
2 - Day Course
|
Rapid Microbiological Methods - RMM
Lecturer: Dr. Michael Miller
|
| |
|
 |
TBA
2 - Day Course
|
Risk Management Throughout a Drug Lifecycle
Lecturer: Dr Stanley Garbus
|
| |
The course is based on the risk (risk/benefit assessment) for prescription drug products but the concept of Risk Management and Mitigation is universal and being recognized by regulatory authorities as necessary for devices and biotech products as well. |
 |
07/12/2010
Day Course
|
Good Clinical Practice 2010 - Clinical Trials for Medical Device
Lecturer: Dr. Monica Tocchi
|
| |
|
 |
08/12/2010
2 - Day Course
|
Clinical Project Management
Lecturer: Dr Stanley Garbus
|
| |
The course begins by describing the basic fundamentals and pharmaceutical industry standards of project management techniques. Details are presented for understanding clinical trial costs and developing timely budgets to create successful study completion on budget. Participants learn skills of leadership, negotiation and communication that will positively impact the success of clinical projects. |
 |
14/12/2010
2 - Day Course
|
Development and Validation of Bioassays
Lecturer: Dr. Ana Menendez, USA
|
| |
The lecture portion of this course will outline sensible approaches to develop reproducible bioassays using live systems and/or biologically derived reagents. These approaches will be supplemented by guidelines to meet regulatory requirements according to their application. In addition, a workshop on writing validation protocols will provide hands-on experience to cover this pivotal document. During the course students will also hear caser studies that will add relevance to the lecture materials and provide a launch point for class discussion. |
 |
16/12/2010
Day Course
|
Fundamentals to Design Strategic Immunogenicity Programs
Lecturer: Dr. Ana Menendez, USA
|
| |
|
 |
19/12/2010
2 - Day Course
|
Dissolution Testing
Lecturer: Dr Malcolm Ross
|
| |
The course looks at the history of the dissolution test in order to understand how we have arrived at today’s situation. It will review the test methods, both official and unofficial and discuss the development and validation of dissolution tests. |
 |
21/12/2010
2 - Day Course
|
A deep Insight into Pharmacovigilance and Risk Management Regulatory Systems, advanced level
Lecturer: Dr. Irene Fermont
|
| |
|
 |
22/12/2010
2 - Day Course
|
Analytical Data Serving the QA, Regulatory & Formulation Staff
Lecturer: Dr Malcolm Ross
|
| |
Analytical chemistry is of major significance in all aspects of the pharmaceutical industry. As staff has become more specialist it is important that people without detailed experience in analytical chemistry understand the fundamental principles involved in order to evaluate the data presented to them. This course is intended to provide a firm basis to enable non-analytical chemists to understand and to evaluate the significance of the data generated in the analytical laboratory. |
 |
27/12/2010
2 - Day Course
|
Optimizing the Drug Development Process using PK/PD Modeling
Lecturer: Dr. Serge Guzy, USA
|
| |
|
 |
|
Past Activities
2010
21/07/2010
2 - Day Course
|
European Drug Regulatory Affairs: Strategy and Practice with European Regulatory Procedures
Lecturer: Dr. David Jacobs, USA
|
| |
|
 |
16/06/2010
2 - Day Course
|
Development of Combination Products - Regulatory & Clinical Considerations
Lecturer: Dr. Barbara Fant
|
| |
|
 |
TBA
Day Course
|
Clinical Leadership and Governance for Trial Sponsors
Lecturer: Dr. Monica Tocchi
|
| |
|
 |
24/03/2010
2 - Day Course
|
RCA - Root Cause Analysis
Lecturer: Dr Malcolm Ross
|
| |
|
 |
22/03/2010
2 - Day Course
|
Medical Device Clinical Studies & Clinical Evaluation for CE Marking in 2010
Lecturer: Dr. Monica Tocchi
|
| |
This course is intended for manufacturers who are planning to bring their devices to the European market and need clinical data to support their product claims according with the new EU Directives, which take effect on March 21, 2010. One key change is the requirement of more clinical data for devices placed on the market in any of the 27 EU member nations. For clinical investigations, there will be more scrutiny of clinical dossiers and communication between authorities, for example, refusal from one country will be shared with all other nations. Devicemakers need practical tools for immediate compliance with the new requirements, that this course will provide. |
 |
21/03/2010
2 - Day Course
|
Formulation for Chemists
Lecturer: Dr Malcolm Ross
|
| |
|
 |
21/02/2010
Meeting
|
Medical Device Companies
Lecturer: Mr. Clay Anselmo
|
| |
This course will give an overview on worldwide regulatory frameworks, discussing how to develop Regulatory and QMS strategies to meet the business needs. |
 |
15/02/2010
2 - Day Course
|
Pharmacovigilance - basic level
Lecturer: Dr. Irene Fermont
|
| |
|
 |
21/01/2010
Day Course
|
CITAC Workshop
Lecturers: Dr.I.Kuselman, Dr. W.Koch, Prof.H.Emons, Prof.I.Leito, Prof. P.De Bievre, Dr. J.Messman
|
| |
The course will cover metrological principles and practice in analytical laboratories important for quality assurance of analytical results, required by GLP & GMP standards, ISO/IEC 17025 standard, spread for competence of testing laboratories, other international documents and regulations. Use of reference materials as measurement standards, calculation of measurement uncertainty of analytical results, traceability of a routine result to national and international measurement standards and System International of Units (SI), interlaboratory comparisons and proficiency testing are the topics of the course. |
 |
19/01/2010
Day Course
|
GMP עיקור בסביבת
Professional management: Ms. Yehudith Wexler
|
| |
Isranalytica 2010 – Related Events |
 |
17/01/2010
Day Course
|
Gel Permeation Chromatrography (GPC) Systems in Pharmaceutical Applications
Lecturer: Dr. Mark Pothecary, UK
|
| |
|
 |
2009
15/12/2009
Day Course
|
The New Euro Directive for Medical Devices
Lecturer: Dr. Christian Jarling
|
| |
This seminar gives instructions how to assemble a Technical File in compliance with the European Directives on Medical Devices. This file shall not only comply with the regulatory requirements, but also give an understanding, what a reviewer / auditor expects from a Technical File. |
 |
TBA
2 - Day Course
|
Powder Technology - The Missing Link in Solid Dosage Formulation
Lecturer: Dr. Malcolm Ross, Switzerland
|
| |
The course will concentrate on solid dosage forms but some mention will be made of other dosage form designs where particle size is critical. |
 |
09/12/2009
2 - Day Course
|
Technology Transfer
Lecturer: Dr Malcolm Ross, Switzerland
|
| |
|
 |
02/12/2009
2 - Day Course
|
Film Coating
Lecturer: Dr. Stuart Porter
|
| |
This course is intended for scientists responsible for the development of film-coated oral solid dosage forms, and scientist, engineers, operators and supervisors responsible for providing technical support with respect to film-coated products. |
 |
TBA
2 - Day Course
|
Registration of Biosimilars in the European Union
Lecturer: Dr. Barbara Jentges
|
| |
|
 |
TBA
2 - Day Course
|
Identification of Drug Metabolites using LC–MS–MS Technologies
Lecturer: Dr. Wilfried Niessen, The Netherlands
|
| |
|
 |
TBA
2 - Day Course
|
Identification of Endogenous Compounds and Natural Products using LC–MS–MS Technologies
Lecturer: Dr. Wilfried Niessen, The Netherlands
|
| |
|
 |
TBA
Day Course
|
How to Prepare for a CMDCAS Audit
Lecturer: Dr. Christian Jarling
|
| |
This seminar is dedicated to manufacturers, who already have a quality management system according to ISO 13485, but who want to integrate the additional regulatory aspects required for Canada. Based on practical examples problem areas and possible solutions will be discussed. |
 |
15/07/2009
Day Course
|
How Current Are You? Review of New Industry and Regulatory Expectations For Biopharmaceutical Products
Lecturer: Dr. Ana Menendez, USA
|
| |
2008 was a banner year for generating important industry white papers and regulatory guidelines for biopharmaceutical products. This meeting specifically addresses updates that should be implemented in post-2009 development and validation programs both in the GMP and the GLP arena. |
 |
13/07/2009
2 - Day Course
|
Development and Validation of Bioassays
Lecturer: Dr. Ana Menendez, USA
|
| |
The lecture portion of this course will outline sensible approaches to develop reproducible bioassays using live systems and/or biologically derived reagents. These approaches will be supplemented by guidelines to meet regulatory requirements according to their application. In addition, a workshop on writing validation protocols will provide hands-on experience to cover this pivotal document. During the course students will also hear caser studies that will add relevance to the lecture materials and provide a launch point for class discussion. |
 |
05/07/2009
2 - Day Course
|
Preparing Protocols & Final Reports for Clinical Trial
Lecturer: Dr. Shayne Gad
|
| |
|
 |
TBA
Day Course
|
Omics Technologies - Theory, Fundamentals, Methods and Applications of – Proteomics, Peptidomics, Glycomics, Metabolomics and Other Omics
Lecturer: Prof. Ira Krull, USA
|
| |
This course will provide a description and summary of various omics approaches in practice today in the pharmaceutical, chemical, biological, biotechnological, and life sciences areas. These scientific fields of study include ones such as: proteomics, peptidomics, metabolomics, glycomics and other omics for both small and large molecules and their interactions. |
 |
TBA
2 - Day Course
|
Medical Device Clinical Studies & Clinical Evaluation for CE Marking
Lecturer: Dr. Monica Tocchi
|
| |
|
 |
17/06/2009
Day Course
|
Modern Thin Layer Chromatography
Lecturer: Mr. Daniel Handloser, Switzerland
|
| |
The course is designed to give a theoretical overview and a practical introduction to the possibilities of modern HPTLC. |
 |
TBA
2 - Day Course
|
Proteins & Related Materials
Lecturer: Prof. Ira Krull
|
| |
The course will provide a description and summary of the current approaches possible for the characterization of recombinant (synthetic) and natural proteins, peptides and antibodies. |
 |
03/06/2009
2 - Day Course
|
Analytical Chemistry for non-analytical chemists
Lecturer: Dr Malcolm Ross, Switzerland
|
| |
Analytical chemistry is of major significance in all aspects of the pharmaceutical industry. As staff has become more specialist it is important that people without detailed experience in analytical chemistry understand the fundamental principles involved in order to evaluate the data presented to them. This course is intended to provide a firm basis to enable non-analytical chemists to understand and to evaluate the significance of the data generated in the analytical laboratory. |
 |
TBA
Day Course
|
The European variations rules & the science behind
Lecturer: Dr. Malcolm Ross, Switzerland
|
| |
This one day course is designed to address those changes which are related to product and production rather than the administrative changes that are related to labeling or change of address etc. This discusses variations from both the regulatory and the technical side and is designed to provide a deeper understanding of the technical process involved for regulatory and registration officers. |
 |
31/05/2009
2 - Day Course
|
Dissolution Testing
Lecturer: Dr. Malcolm Ross, Switzerland
|
| |
The course looks at the history of the dissolution test in order to understand how we have arrived at today’s situation. It will review the test methods, both official and unofficial and discuss the development and validation of dissolution tests. |
 |
25/05/2009
2 - Day Course
|
Managing Extractables and Leachables in Pharmaceutical Products
Lecturer: Ph.D. Edward J. Smith
|
| |
This course will review guidance documents, and other regulations regarding the identification, measurement, toxicological qualification, and reporting of extractables/leachables from packaging and process materials into pharmaceutical and biotech products. Included in the course is a detailed discussion of the sources of extractables from glass, rubber, and plastic packaging and process components and the work of the Product Quality Research Institute (PQRI) on inhalation, ophthalmic, and parenteral products. Examples will also be presented to demonstrate how E&L issues can be mitigated through the judicious choice of packaging components and materials. |
 |
18/05/2009
2 - Day Course
|
Patient Recruitment Strategy: A Comprehensive Workshop for Investigative Sites and Sponsors
Lecturer: Mr. John Needham (USA)
|
| |
The course focuses on the skills of the people who are responsible for recruitment success including their personal development (Me), their relationship with their immediate supervisor or client (We) and the role of their efforts in the overall study and the public’s health (Us). |
 |
12/05/2009
Day Course
|
Validation of Analytical Methods for Proteins
Lecturer: Prof. Ira Krull, USA
|
| |
The course will provide a description and summary of how to develop, optimize, and validate analytical methods for small and large biomolecules. The course will pursue commonly found protein variants and posttranslational modifications in biopharmaceutical products, and how these are commonly assayed for today. Current FDA requirements for protein biopharmaceutical products will also be explored and intensively discussed. |
 |
04/05/2009
2 - Day Course
|
Capsule Technology & Encapsulation of Commercial & Clinical Supplies
Lecturer: Mr. Donald K. Lightfoot, USA
|
| |
A comprehensive capsule technology presentation covering the manufacturing of empty and filled two piece capsules, fundamentals of encapsulation, blinding of clinical supplies utilizing over-encapsulation and an extensive review of the encapsulation machinery and equipment. |
 |
TBA
2 - Day Course
|
Sterilization by Radiation
Lecturer: Mr. Martell Winters, USA
|
| |
|
 |
TBA
2 - Day Course
|
Ethylene Oxide Sterilization
Lecturer: Mr. Daniel Floyd, USA
|
| |
Join us for this two day workshop offering an opportunity to further your understanding of microbiological basics, sterilization basics, ethylene oxide sterilization methods, and discussions on the appropriate way to develop, validate, and optimize your sterilization cycle. |
 |
11/02/2009
Day Course
|
Risk Management Strategy Planning
Lecturer: Dr. Malcolm Ross, Switzerland
|
| |
Although risk management in the industry is not new, recently the Regulatory Authorities are making it a formal requirement through such initiatives as ICH Q9 [Quality Risk Management] and the FDA’s Risk Evaluation and Mitigation Strategy for new drugs. |
 |
TBA
2 - Day Course
|
RCA - Root Cause Analysis
Lecturer: Dr. Malcolm Ross, Switzerland
|
| |
Participants will learn how the need to undertake investigations in a systematic manner came about. They will learn the philosophies of different systems that are used in various industries such as CAPA, FMEA, PHA and HAZOP and the difference between reactive and proactive systems. |
 |
22/01/2009
Day Course
|
Chiral Recognition and Separation Mechanisms
Lecturer: Prof. Nelu Grinberg, USA
|
| |
The course will focus on specific interactions between the enantiomeric analytes and each specific chiral stationary phase, rather than the techniques used to separate enantiomers. This approach will allow the participants to understand the strategies for development of a separation of enantiomers, along with the conditions to achieve each type of interaction. |
 |
2008
17/12/2008
2 - Day Course
|
Pharmaceutical Packaging Technology
Lecturer: Mr. David Williams, UK
|
| |
This intensive course will provide delegates with the knowledge of how packs, for packaging of ethical, OTC and veterinary medicines, are developed, manufactured, filled, transported, stored and used. Packaging is a fundamental part of every marketed product and frequently is fundamental in the success of the product. |
 |
16/12/2008
Day Course
|
Closure manufacture, use & testing
Lecturer: Mr. David Williams, UK
|
| |
This one-day workshop will provide delegates with the knowledge of how packs are closed to maximise protection of ethical and OTC medicines. A successfully closed pack is a fundamental part of every marketed product and is vital to ensure the success of the product. |
 |
TBA
Day Course
|
Theory, Fundamentals, Methods and Applications of Omics Technologies – Proteomics, Peptidomics, Glycomics, Metabolomics and Other Omics
Lecturer: Prof. Ira Krull
|
| |
This course will provide a description and summary of various omics approaches in practice today in the pharmaceutical, chemical, biological, biotechnological, and life sciences areas. These scientific fields of study include ones such as: proteomics, peptidomics, metabolomics, glycomics and other omics for both small and large molecules and their interactions. |
 |
TBA
2 - Day Course
|
Proteins & Related Materials
Lecturer: Prof. Ira Krull
|
| |
The course will provide a description and summary of the current approaches possible for the characterization of recombinant (synthetic) and natural proteins, peptides and antibodies. |
 |
04/11/2008
2 - Day Course
|
CMC Submissions in the CTD Format
Lecturer: Carolyn H. Kruse, USA
|
| |
This course will address the regional requirements and the differences in approaches to document review for the three ICH territories: US, EU and Japan. This course will provide an in depth review of the chemistry, manufacturing and controls (CMC) requirements for development and ultimate submission to the FDA and other Regulatory Authorities for the new drug applications (NDA’s). |
 |
07/09/2008
2 - Day Course
|
Pharmaceutical Product Risk
Lecturer: Dr Stanley Garbus (USA)
|
| |
The course is based on the risk (risk/benefit assessment) for prescription drug products but the concept of Risk Management and Mitigation is universal and being recognized by regulatory authorities as necessary for devices and biotech products as well. |
 |
03/09/2008
2 - Day Course
|
Clinical Project Management
Lecturer: Dr Stanley Garbus - USA
|
| |
The course begins by describing the basic fundamentals and pharmaceutical industry standards of project management techniques. Details are presented for understanding clinical trial costs and developing timely budgets to create successful study completion on budget. Participants learn skills of leadership, negotiation and communication that will positively impact the success of clinical projects. |
 |
TBA
Day Course
|
Efficiency in Quality Operation & Managing Batch Records
Lecturer: Mr. Rafi Maslaton - USA
|
| |
In today's business environment, a quality organization that focuses strictly on compliance while ignoring inefficiency will not succeed. This course discusses efficiency management throughout the quality operations with the main focus on batch record release. While for many years QA was predominantly a compliance organization, and it existence was associated with the cost of doing business, this course will outline how we can manage both compliance and efficiency. |
 |
07/07/2008
2 - Day Course
|
Technology Transfer
Lecturer: Dr. Malcolm Ross, Switzerland
|
| |
|
 |
04/06/2008
2 - Day Course
|
Powder Technology - The Missing Link
Lecturer: Dr. Malcolm Ross, Switzerland
|
| |
The course will concentrate on solid dosage forms but some mention will be made of other dosage form designs where particle size is critical. |
 |
02/06/2008
3 - Day Course
|
The Analysis and Characterization of Protein Therapeutic Drugs
Lecturer: Mr. David Carr, USA
|
| |
This is a focused course of instruction on the instrumental analysis and characterization of polypeptides. The course emphasizes three important instrumental analytical technologies as they relate to the analysis and characterization of protein therapeutics |
 |
12/05/2008
3 - Day Course
|
Developing Clinical Quality Assurance Audit Skills and Procedures (CQA)
Lecturer: Mr. Steve Schwartz
|
| |
Roles and Responsibilities for Auditors and Managers
|
 |
07/04/2008
2 - Day Course
|
RCA - Root Cause Analysis
Lecturer: Dr. Malcolm Ross, Switzerland
|
| |
Participants will learn how the need to undertake investigations in a systematic manner came about. They will learn the philosophies of different systems that are used in various industries such as CAPA, FMEA, PHA and HAZOP and the difference between reactive and proactive systems. |
 |
TBA
2 - Day Course
|
Analyzing Biological Assays
Lecturer: Dr. John Dunn (USA)
|
| |
The course covers nonlinear curve fitting, parallelism and other computations as they relate to bioassay optimization and analysis, and a comprehensive method for evaluating and troubleshooting failed reagents and incubation conditions. |
 |
26/02/2008
2 - Day Course
|
Film Coating
Lecturer: Dr. Stuart Porter
|
| |
This course is intended for scientists responsible for the development of film-coated oral solid dosage forms, and scientist, engineers, operators and supervisors responsible for providing technical support with respect to film-coated products. |
 |
19/02/2008
2 - Day Course
|
Medical Device Clinical Studies in Europe & Clinical Evaluation for CE Marking
Lecturer: Dr. Monica Tocchi, Italy
|
| |
|
 |
TBA
2 - Day Course
|
Regulatory and Clinical Considerations in the Development of Combination Products
Lecturer: Dr. Barbara S. Fant, Pharm.D., USA
|
| |
Development and FDA approval of a combination product is inherently more complex than individual entity products. This course will provide an overview of the regulatory pathway and the development lifecycle for combination products. Characteristics that are common and those that are unique to medical device, drug, and biologic development will be presented. Considerations in clinical trial design, project management, and clinical monitoring of combination product clinical trials will be presented.
|
 |
2006
|
| |
|
 |
All Rights Reserved 2006. Bioforum.org.il
P.O.B. 4034 Ness Ziona, Israel, 70400, Phone: +972-8-931-3070, Fax: +972-8-931-3071
|
Created by WebStudio.co.il
|
|
|
 |